Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabiana Perna

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2021
Safety Starts with Selecting the TargetsFabiana Perna
Frontiers in Immunology|January 6, 2023
Targets for chimeric antigen receptor T-cell therapy of acute myeloid leukemiaChristopher Schorr, Fabiana Perna
Translational Cancer Research|August 22, 2017
Myeloid leukemia switch as immune escape from CD19 chimeric antigen receptor (CAR) therapyFabiana Perna, Michel Sadelain
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 21, 2023
Tailoring CAR T cell technology for T cell leukemiaChristopher Schorr, Fabiana Perna
Pediatric Reports|November 5, 2011
Aplastic anemia: immunosuppressive therapy in 2010Antonio M Risitano, Fabiana Perna
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2024
Shifting gears with CAR T cells for autoimmune diseasesBrandon Kale, Mohsen Khosravi-Maharlooei, Fabiana Perna
Transplantation and Cellular Therapy|July 5, 2025
On the Road to Safer CAR Therapy for B-Cell Lymphoma: Real-World EvidenceTiara DaCosta-Clark, Brandon Kale, Fabiana Perna
Blood|March 6, 2023
How I treat unique and difficult-to-manage cases of CAR T-cell therapy-associated neurotoxicityBianca D Santomasso, Juliane Gust, Fabiana Perna
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2024
mRNA-based therapeutic strategies for cancer treatmentThilelli Taibi, Sehyun Cheon, Fabiana Perna, et al.
Nature Reviews. Cancer|May 26, 2016
Beyond transcription factors: how oncogenic signalling reshapes the epigenetic landscapeFan Liu, Lan Wang, Fabiana Perna, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2021
Safety Starts with Selecting the TargetsFabiana Perna
Frontiers in Immunology|January 6, 2023
Targets for chimeric antigen receptor T-cell therapy of acute myeloid leukemiaChristopher Schorr, Fabiana Perna
Translational Cancer Research|August 22, 2017
Myeloid leukemia switch as immune escape from CD19 chimeric antigen receptor (CAR) therapyFabiana Perna, Michel Sadelain
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 21, 2023
Tailoring CAR T cell technology for T cell leukemiaChristopher Schorr, Fabiana Perna
Pediatric Reports|November 5, 2011
Aplastic anemia: immunosuppressive therapy in 2010Antonio M Risitano, Fabiana Perna
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2024
Shifting gears with CAR T cells for autoimmune diseasesBrandon Kale, Mohsen Khosravi-Maharlooei, Fabiana Perna
Transplantation and Cellular Therapy|July 5, 2025
On the Road to Safer CAR Therapy for B-Cell Lymphoma: Real-World EvidenceTiara DaCosta-Clark, Brandon Kale, Fabiana Perna
Blood|March 6, 2023
How I treat unique and difficult-to-manage cases of CAR T-cell therapy-associated neurotoxicityBianca D Santomasso, Juliane Gust, Fabiana Perna
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2024
mRNA-based therapeutic strategies for cancer treatmentThilelli Taibi, Sehyun Cheon, Fabiana Perna, et al.
Nature Reviews. Cancer|May 26, 2016
Beyond transcription factors: how oncogenic signalling reshapes the epigenetic landscapeFan Liu, Lan Wang, Fabiana Perna, et al.
Pageof 8